A s.394 (Unfair dismissal) claim by Sabri Khan Yazgan against Australian Pharmaceutical Industries Limited has been rejected by Senior Deputy President Hamberger in Sydney on 4 July 2018.
FEATURED
Retirement apartments to be woven into mixed-use development
Thousands of dementia sufferers are being denied new miracle drug
Property group reveals revised mixed-use housing development plans
Best retirement housing design for Global Awards shortlisted
Vision for affordable and sustainable multigenerational housing canvassed by experts
Intergenerational social housing boom in particular now underway
INNOVATION
